PEMETREXED VERSUS PEMETREXED PLUS CARBOPLATIN IN PRETREATED PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER: A POOLED ANALYSIS OF TWO RANDOMIZED TRIALS

被引：0
|
作者：
Tiseo, Marcello [1 ]
Ardizzoni, Andrea [1 ]
Boni, Luca [2 ]
Vincent, A. [3 ]
Buti, S.
Camerini, Andrea
Labianca, R. [4 ]
Genestreti, Giovenzio [5 ]
Zanelli, Francesca [6 ]
Ciuffreda, L. [7 ]
Di Costanzo, F. [8 ]
De Marinis, F. [9 ]
Crino, Lucio [10 ]
Santo, A. [11 ]
Pazzola, A. [12 ]
Barbieri, F. [13 ]
Zilembo, N. [14 ]
Colantonio, I. [15 ]
Tibaldi, C. [16 ]
Smit, Egbert F. [17 ]
机构：
[1] Univ Hosp Parma, Med Oncol Unit, Parma, Italy
[2] Ist Toscano Tumori, Coordinamento Sperimentaz Clin 4Ctr, Genoa, Italy
[3] Natl Canc Inst, Amsterdam, Netherlands
[4] Osped Riuniti Bergamo, Bergamo, Italy
[5] Irst Meldola, Oncol, Melola, Italy
[6] Osped Reggio Emilia, Reggio Emilia, Italy
[7] Osped Molinette, Molinette, Italy
[8] Osped Careggi, Florence, Italy
[9] San Camillo Forlanini, Rome, Italy
[10] Osped Perugia, Perugia, Italy
[11] Osped Verona, Verona, Italy
[12] Osped Sassari, Sassari, Italy
[13] Policlin Modena, Modena, Italy
[14] Ist Nazl Tumori, Naples, Italy
[15] Osped Cuneo, Cuneo, Italy
[16] Osped Livorno, Livorno, Italy
[17] Vrije Univ, Med Ctr, Pulmonol Dept, Amsterdam, Netherlands
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
NSCLC; second-line chemotherapy; Pemetrexed; Carboplatin;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：S415 / S415
页数：1
相关论文
共 50 条
  • [1] Pemetrexed versus pemetrexed plus carboplatin in pretreated patients with advanced non-small cell lung cancer (NSCLC): Pooled analysis of two randomized trials.
    Ardizzoni, A.
    Boni, L.
    Tiseo, M.
    Vincent, A.
    Passalacqua, R.
    Camerini, A.
    Labianca, R.
    Genestreti, G.
    Zanelli, F.
    Ciuffreda, L.
    Di Costanzo, F.
    De Marinis, F.
    Crino, L.
    Santo, A.
    Pazzola, A.
    Barbieri, F.
    Zilembo, N.
    Colantonio, I.
    Tibaldi, C.
    Smit, E. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] Pemetrexed plus carboplatin or oxaliplatin in advanced non-small cell lung cancer
    Scagliotti, GV
    SEMINARS IN ONCOLOGY, 2005, 32 (02) : S5 - S8
  • [3] Randomized Phase II and Pharmacogenetic Study of Pemetrexed Compared With Pemetrexed Plus Carboplatin in Pretreated Patients With Advanced Non-Small-Cell Lung Cancer
    Smit, Egbert F.
    Burgers, Sjaak A.
    Biesma, Bonne
    Smit, Hans J. M.
    Eppinga, Pier
    Dingemans, Anne-Marie C.
    Joerger, Markus
    Schellens, Jan H.
    Vincent, Andrew
    van Zandwijk, Nico
    Groen, Harry J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (12) : 2038 - 2045
  • [4] Randomized phase II study of pemetrexed plus carboplatin followed by pemetrexed versus paclitaxel plus carboplatin followed by pemetrexed in advanced nonsquamous, non-small cell lung cancer (LOGIK 0904)
    Takayama, Koichi
    Inoue, Koji
    Takeshita, Masafumi
    Tashiro, Naoki
    Harada, Taishi
    Seto, Takashi
    Imanaga, Tomotoshi
    Fujimoto, Noriko
    Nakagaki, Noriaki
    Kawasaki, Masayuki
    Kishimoto, Junji
    Ichinose, Yukito
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] RANDOMIZED PHASE II STUDY OF PEMETREXED PLUS CARBOPLATIN FOLLOWED BY PEMETREXED VERSUS PACLITAXEL PLUS CARBOPLATIN FOLLOWED BY PEMETREXED IN ADVANCED NON-SQUAMOUS, NON-SMALL CELL LUNG CANCER (LOGIK 0904)
    Shiraishi, Yoshimasa
    Inoue, Koji
    Takeshita, Masafumi
    Harada, Taishi
    Tashiro, Naoki
    Seto, Takashi
    Imanaga, Tomotoshi
    Fujimoto, Noriko
    Nakagaki, Noriaki
    Kawasaki, Masayuki
    Kishimoto, Junji
    Takayama, Koichi
    Ichinose, Yukito
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S403 - S404
  • [6] Comparison of pemetrexed plus cisplatin versus pemetrexed plus carboplatin in the initial treatment of locally advanced or metastatic non-small cell lung cancer
    Pereira, A. A. R.
    Lessa, R. C.
    Souza, C. E. P.
    Pinto, F. A. I.
    Gagliato, D. M.
    Santos, E. S.
    Fanelli, M. F.
    Rinck, J. A.
    Dettino, A. A.
    Nicolau, U. R.
    Chinen, L. T. D.
    de Lima, V. C. C.
    Pereira, J. R.
    Cruz, M. R. D. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] RANDOMIZED PHASE II STUDY OF PEMETREXED COMPARED WITH PEMETREXED PLUS CARBOPLATIN IN PRETREATED PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (GOIRC 02/2006): PRELIMINARY RESULTS
    Tiseo, M.
    Boni, L.
    Passalacqua, R.
    Camerini, A.
    Labianca, R.
    Amadori, D.
    Boni, C.
    Ciuffreda, L.
    Di Costanzo, F.
    Ardizzoni, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 138 - 138
  • [8] Pemetrexed for Heavily Pretreated Patients With Advanced Non-small Cell Lung Cancer
    Lee, Jih-Hsiang
    Yu, Chong-Jen
    Chen, Kuan-Yu
    Shih, Jin-Yuan
    Lin, Yu-Lin
    Yang, Chih-Hsin
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2010, 109 (05) : 338 - 344
  • [9] Carboplatin plus pemetrexed for platinum-pretreated, advanced non-small cell lung cancer: a retrospective study with pharmacogenetic evaluation
    Giulio Metro
    R. Chiari
    M. Mare
    D. Giannarelli
    F. R. Tofanetti
    V. Minotti
    M. Ferraldeschi
    D. Giuffrida
    L. Marcomigni
    C. Bennati
    M. J. Fischer
    M. Meacci
    R. Bellavita
    L. Pistola
    V. Ludovini
    L. Crinò
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 1405 - 1412
  • [10] Carboplatin plus pemetrexed for platinum-pretreated, advanced non-small cell lung cancer: a retrospective study with pharmacogenetic evaluation
    Metro, Giulio
    Chiari, R.
    Mare, M.
    Giannarelli, D.
    Tofanetti, F. R.
    Minotti, V.
    Ferraldeschi, M.
    Giuffrida, D.
    Marcomigni, L.
    Bennati, C.
    Fischer, M. J.
    Meacci, M.
    Bellavita, R.
    Pistola, L.
    Ludovini, V.
    Crino, L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (06) : 1405 - 1412
12345